Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke

BACKGROUND: Studies have suggested that glycoprotein IIb/IIIa antagonists such as tirofiban are beneficial for patients with acute coronary syndromes. However, it is still uncertain about the efficacy and safety of tirofiban in patients with acute ischemic stroke (AIS). METHODS: In this prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Chunrong, Zhu, Yuyou, Zhang, Chao, Song, Jianlong, Liu, Tianlong, Yuan, Xiaodong, Luo, Wenwu, Chen, Changchun, Liu, Dezhi, Zhu, Yuanyuan, Liu, Jie, Hu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223269/
https://www.ncbi.nlm.nih.gov/pubmed/34167477
http://dx.doi.org/10.1186/s12883-021-02268-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223269/
https://www.ncbi.nlm.nih.gov/pubmed/34167477
http://dx.doi.org/10.1186/s12883-021-02268-8

Ejemplares similares